| Genotype–phenotype relations in primary familial brain calcification: systematic MDSGene review A Balck, S Schaake, NS Kuhnke, A Domingo, H Madoev, J Margolesky, ... Movement Disorders 36 (11), 2468-2480, 2021 | 51 | 2021 |
| Gender disparities in deep brain stimulation for Parkinson's disease DS Shpiner, DG Di Luca, I Cajigas, JS Diaz, J Margolesky, H Moore, ... Neuromodulation: Technology at the Neural Interface 22 (4), 484-488, 2019 | 42 | 2019 |
| How tandem gait stumbled into the neurological exam: a review J Margolesky, C Singer Neurological Sciences 39 (1), 23-29, 2018 | 37 | 2018 |
| Extended-release oral capsule of carbidopa–levodopa in Parkinson disease J Margolesky, C Singer Therapeutic advances in neurological disorders 11, 1756285617737728, 2018 | 28 | 2018 |
| A critical analysis of 57 cases of Hughes-Stovin syndrome (HSS). A report by the HSS International Study Group (HSSISG) Y Emad, Y Ragab, M Kechida, A Guffroy, M Kindermann, C Robinson, ... International journal of cardiology 331, 221-229, 2021 | 26 | 2021 |
| Minority enrollment in Parkinson’s disease clinical trials: meta-analysis and systematic review of studies evaluating treatment of neuropsychiatric symptoms DG Di Luca, JA Sambursky, J Margolesky, JG Cordeiro, A Diaz, ... Journal of Parkinson's disease 10 (4), 1709-1716, 2020 | 22 | 2020 |
| Trends of inpatient palliative care use among hospitalized patients with Parkinson's disease DG Di Luca, M Feldman, S Jimsheleishvili, J Margolesky, JG Cordeiro, ... Parkinsonism & related disorders 77, 13-17, 2020 | 19 | 2020 |
| Pulmonary vasculitis in Hughes-Stovin syndrome (HSS): a reference atlas and computed tomography pulmonary angiography guide—a report by the HSS International Study Group Y Emad, Y Ragab, C Robinson, S Pankl, P Young, M Fabi, P Bawaskar, ... Clinical rheumatology 40, 4993-5008, 2021 | 18 | 2021 |
| Amantadine revisited: a contender for initial treatment in Parkinson’s disease? S Marmol, M Feldman, C Singer, J Margolesky CNS drugs 35, 1141-1152, 2021 | 18 | 2021 |
| Transverse myelitis presenting in a patient with Hughes-Stovin syndrome J Margolesky, L Tornes, A Vosoughi Multiple sclerosis and related disorders 4 (3), 281-283, 2015 | 15 | 2015 |
| Revisiting eligibility for deep brain stimulation: Do preoperative mood symptoms predict outcomes in Parkinson's disease patients? M Sarno, W Gaztanaga, N Banerjee, A Bure-Reyes, J Rooks, ... Parkinsonism & related disorders 63, 131-136, 2019 | 14 | 2019 |
| Management of urologic and sexual dysfunction in Parkinson disease J Margolesky, S Betté, C Singer Clinics in geriatric medicine 36 (1), 69-80, 2020 | 12 | 2020 |
| Development of an equity, diversity, inclusion, and anti-racism pledge as the foundation for action in an academic department of neurology GL Gordon Perue, SE Fox-Rosellini, NB Sur, E Marulanda-Londono, ... Neurology 97 (15), 729-736, 2021 | 10 | 2021 |
| Tandem gait abnormality in Parkinson disease: prevalence and implication as a predictor of fall risk J Margolesky, S Bette, DS Shpiner, EA Jordan, C Dong, T Rundek, ... Parkinsonism & related disorders 63, 83-87, 2019 | 9 | 2019 |
| Opicapone for the treatment of Parkinson’s disease: a review M Feldman, J Margolesky International Journal of Neuroscience 133 (5), 532-543, 2023 | 8 | 2023 |
| Updated perspectives on the management of drug-induced parkinsonism (DIP): Insights from the clinic M Feldman, S Marmol, J Margolesky Therapeutics and clinical risk management, 1129-1142, 2022 | 7 | 2022 |
| Perivascular spaces in basal ganglia—An innocent bystander in Parkinson's disease? T Rundek, DS Shpiner, J Margolesky Movement Disorders 34 (11), 1585-1587, 2019 | 7 | 2019 |
| HSV-2 encephalitis presenting as multifocal ischemic stroke F Zhang, A Sumida, J Margolesky, L Tornes, A Ramos, S Koch Neurological Sciences 38, 2229-2230, 2017 | 7 | 2017 |
| Subthalamic nucleus deep brain stimulation for the treatment of secondary dystonia: A case series and review of literature J Margolesky, N Schoen, W Jermakowicz, S Sur, I Cajigas, C Singer, ... Brain stimulation 10 (4), 870-872, 2017 | 7 | 2017 |
| CVT-301 for the treatment of Parkinson’s disease DS Shpiner, S Bette, DG Di Luca, J Margolesky Expert review of neurotherapeutics 19 (7), 603-611, 2019 | 6 | 2019 |
